17 December 2020
The pharma field sales force was essentially shut down due to COVID-19 and will likely never return to the way it was pre-pandemic. COVID-19 severely restricted face-to-face interactions, revealing a critical communication gap that put patients at risk. As a digital health and communications platform connecting life sciences to the point of care, OptimizeRx moved quickly to launch TelaRep in April 2020.
Read the full mention here.
"Our [PM360's] 9th Annual Innovations Issue is filled with examples of organizations that acted quickly to find and develop innovative new ways to help physicians, patients, payers, and hospitals impacted by COVID. They didn’t hesitate—not even for a second. Some of these new offerings were launched weeks—and in some cases days—after COVID started shutting things down in March."
OptimizeRx Corporation (NASDAQ: OPRX) is a pioneering digital health company that provides healthcare communications solutions for life sciences to engage in streamlined, outcomes-focused dialogue with healthcare providers and patients. Connecting more than half of healthcare providers in the US through a proprietary electronic health network, the OptimizeRx digital health and communications platform is a SaaS solution supporting treatment access and adherence by advancing affordability and transparency. The platform unlocks novel patient and provider touchpoints for life sciences along the complete longitudinal patient journey, from both ambulatory and hospital point-of-care, to retail pharmacy, through patient engagement outside the care setting.
OptimizeRx Corporation
+1 (248) 651-6568